Find clinical trials for Melanoma in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Hanyang, Seoul, KOR:
alone in participants with untreated, unresectable or metastatic melanoma. Participants randomized to the pembrolizumab monotherapy arm who ...
Phase 3
Seongnam-si, Gyeonggi-do, Korea, Republic of and 62 other locations
(PK) similarity and efficacy, safety, and immunogenicity of ABP 206 compared with OPDIVO® (nivolumab) in subjects with resected advanced melanoma...
Phase 3
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, Korea, Republic of and 110 other locations
This study observes the antitumor activity, safety, tolerability, PK, and pharmacodynamics in patients with inoperable and/or metastatic melanoma...
Phase 2
Seoul, Seodaemun-Gu, Korea, Republic of and 43 other locations
assess the efficacy, safety, and immunogenicity of ABP 206 compared with Nivolumab in Subjects with Treatment-Naïve Unresectable or Metastatic Melanoma...
Phase 3
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, Korea, Republic of and 173 other locations
of ceralasertib, when administered as monotherapy and in combination with durvalumab in participants with unresectable or advanced melanoma ...
Phase 2
Seoul, Korea, Republic of and 65 other locations
combined with nivolumab in patients with unresectable or metastatic melanoma. A separate open-label cohort of adults with new, progressive b...
Phase 3
Seoul, Gyeonggi, Korea, Republic of and 138 other locations
belvarafenib as a single agent and in combination with either cobimetinib or cobimetinib plus nivolumab in patients with NRAS-mutant advanced melanoma...
Phase 1
Seoul, Korea, Republic of and 13 other locations
to pembrolizumab with respect to RFS as assessed by the investigator in participants with high-risk resected Stage IIB, IIC, III and IV melanoma...
Phase 3
Seoul, Korea, Republic of and 204 other locations
is safe and prevents cancer from returning in people with high-risk melanoma. Researchers want to know if V940 with pembrolizumab is better ...
Phase 3
Seoul, Korea, Republic of and 165 other locations
This is a Phase 1b/2, multi-center, open label umbrella study of patients ≥12 years of age with recurrent, progressive, or refractory melanoma...
Phase 1, Phase 2
Seoul, Korea, Republic of and 19 other locations
Clinical trials
Research sites
Resources
Legal